TherapeuticsMD, Inc. short interest in 2018
In 2018, TherapeuticsMD, Inc.'s disclosed short interest ran from 24.66% of shares outstanding on 12 Jan 2018 to 29.49% on 31 Dec 2018, a change of +4.83 percentage points. The year's high was 32.12% on 31 Oct 2018 and its low 24.22% on 31 Jan 2018, averaging 27.75% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 43.47 days on 13 Jul 2018. Full history: TherapeuticsMD, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2018 in figures
- Start of year
- 24.66% (12 Jan 2018)
- End of year
- 29.49% (31 Dec 2018)
- Change
- +4.83 pp
- High
- 32.12% (31 Oct 2018)
- Low
- 24.22% (31 Jan 2018)
- Average
- 27.75%
- Highest days to cover
- 43.47 (13 Jul 2018)
- SEC filings marked
- 8
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 24.66% | 32.80 | |
| 31 Jan 2018 | 24.22% | 30.53 | |
| 15 Feb 2018 | 25.22% | 26.58 | |
| 28 Feb 2018 | 25.90% | 26.97 | results (8-K), 10-K filed |
| 15 Mar 2018 | 26.77% | 28.68 | |
| 29 Mar 2018 | 26.57% | 29.85 | |
| 13 Apr 2018 | 27.04% | 25.11 | |
| 30 Apr 2018 | 26.56% | 31.31 | |
| 15 May 2018 | 25.44% | 20.02 | results (8-K), 10-Q filed |
| 31 May 2018 | 27.40% | 11.75 | |
| 15 Jun 2018 | 27.55% | 11.77 | |
| 29 Jun 2018 | 27.27% | 22.88 | |
| 13 Jul 2018 | 27.45% | 43.47 | |
| 31 Jul 2018 | 26.85% | 29.44 | 10-Q filed, results (8-K) |
| 15 Aug 2018 | 27.71% | 20.18 | |
| 31 Aug 2018 | 28.41% | 27.15 | |
| 14 Sep 2018 | 28.93% | 28.89 | |
| 28 Sep 2018 | 30.22% | 27.62 | |
| 15 Oct 2018 | 30.77% | 20.88 | |
| 31 Oct 2018 | 32.12% | 18.89 | |
| 15 Nov 2018 | 29.04% | 21.44 | results (8-K), 10-Q filed |
| 30 Nov 2018 | 30.65% | 30.65 | |
| 14 Dec 2018 | 29.76% | 22.77 | |
| 31 Dec 2018 | 29.49% | 16.30 |
See also: TherapeuticsMD, Inc.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.